Orchestra BioMed Holdings, Inc. financial data

Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Union Square Drive, New Hope, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Health Sciences Acquisitions Corp 2 (to 1/26/2023)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 489 % -38.3%
Quick Ratio 1.03 % -15.5%
Debt-to-equity 66.2 %
Return On Equity -135 % -132%
Return On Assets -79.6 % -92%
Operating Margin -2.44K % -30.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.3M shares +7.09%
Common Stock, Shares, Outstanding 38.2M shares +6.76%
Entity Public Float 125M USD +1.06%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 36.8M shares +10.8%
Weighted Average Number of Shares Outstanding, Diluted 36.8M shares +10.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.64M USD -4.42%
Cost of Revenue 204K USD +9.68%
Research and Development Expense 42.8M USD +26.6%
Costs and Expenses 66.9M USD +23.4%
Operating Income (Loss) -64.3M USD -24.8%
Net Income (Loss) Attributable to Parent -61M USD -24.2%
Earnings Per Share, Basic -1.66 USD/shares -12.2%
Earnings Per Share, Diluted -1.66 USD/shares -12.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.3M USD -27.2%
Marketable Securities, Current 44.6M USD -21.8%
Accounts Receivable, after Allowance for Credit Loss, Current 92K USD -7.07%
Inventory, Net 173K USD +18.5%
Assets, Current 69.2M USD -22.4%
Property, Plant and Equipment, Net 1.38M USD +8.21%
Operating Lease, Right-of-Use Asset 2.1M USD +35.2%
Assets 76.2M USD -20%
Accounts Payable, Current 5.13M USD +77%
Employee-related Liabilities, Current 2.61M USD -1.84%
Accrued Liabilities, Current 6.08M USD +18.2%
Liabilities, Current 16.2M USD +44.6%
Deferred Income Tax Liabilities, Net 561K USD +10.4%
Operating Lease, Liability, Noncurrent 1.69M USD +62.5%
Other Liabilities, Noncurrent 40K USD
Liabilities 43.2M USD +59.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 52K USD
Retained Earnings (Accumulated Deficit) -310M USD -24.5%
Stockholders' Equity Attributable to Parent 99.8M USD +127788%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 33M USD -51.6%
Liabilities and Equity 76.2M USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +8.81%
Net Cash Provided by (Used in) Financing Activities 56.8M USD +129%
Net Cash Provided by (Used in) Investing Activities 5.86M USD
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 38.2M shares +6.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.24M USD -564%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.3M USD -27.2%
Deferred Tax Assets, Valuation Allowance 93.9M USD +56.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.5 pure
Deferred Tax Assets, Gross 94.5M USD +55.8%
Operating Lease, Liability 2.24M USD +32.6%
Depreciation 308K USD +7.32%
Payments to Acquire Property, Plant, and Equipment 8K USD -77.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -61M USD -24.1%
Lessee, Operating Lease, Liability, to be Paid 2.61M USD +39.4%
Property, Plant and Equipment, Gross 2.69M USD +15.7%
Operating Lease, Liability, Current 550K USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 880K USD +150%
Lessee, Operating Lease, Liability, to be Paid, Year One 744K USD +2.34%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +64%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 375K USD +101%
Lessee, Operating Lease, Liability, to be Paid, Year Three 829K USD +136%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 159K USD -54.8%
Operating Lease, Payments 228K USD +11.2%
Additional Paid in Capital 343M USD +8.17%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 74K USD +4.23%
Deferred Tax Assets, Net of Valuation Allowance 561K USD +10.4%
Operating Leases, Future Minimum Payments Due 2.49M USD
Interest Expense 351K USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%